Titre : Protéines Escherichia coli

Protéines Escherichia coli : Questions médicales fréquentes

Termes MeSH sélectionnés :

Multicenter Studies as Topic
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Protéines Escherichia coli : Questions médicales les plus fréquentes", "headline": "Protéines Escherichia coli : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Protéines Escherichia coli : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-28", "dateModified": "2025-04-22", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Protéines Escherichia coli" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Protéines bactériennes", "url": "https://questionsmedicales.fr/mesh/D001426", "about": { "@type": "MedicalCondition", "name": "Protéines bactériennes", "code": { "@type": "MedicalCode", "code": "D001426", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.097" } } }, "about": { "@type": "MedicalCondition", "name": "Protéines Escherichia coli", "alternateName": "Escherichia coli Proteins", "code": { "@type": "MedicalCode", "code": "D029968", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Peter L Freddolino", "url": "https://questionsmedicales.fr/author/Peter%20L%20Freddolino", "affiliation": { "@type": "Organization", "name": "Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan, United States of America." } }, { "@type": "Person", "name": "Lei Yin", "url": "https://questionsmedicales.fr/author/Lei%20Yin", "affiliation": { "@type": "Organization", "name": "Livestock and Poultry Epidemic Diseases Research Center of Anhui Province, Institute of Animal Husbandry and Veterinary Science, Anhui Academy of Agricultural Sciences, Hefei, Anhui 230031, China." } }, { "@type": "Person", "name": "Xiaocheng Pan", "url": "https://questionsmedicales.fr/author/Xiaocheng%20Pan", "affiliation": { "@type": "Organization", "name": "Livestock and Poultry Epidemic Diseases Research Center of Anhui Province, Institute of Animal Husbandry and Veterinary Science, Anhui Academy of Agricultural Sciences, Hefei, Anhui 230031, China. Electronic address: pxcpyq@sina.com." } }, { "@type": "Person", "name": "Kezong Qi", "url": "https://questionsmedicales.fr/author/Kezong%20Qi", "affiliation": { "@type": "Organization", "name": "Anhui Province Key Laboratory of Veterinary Pathobiology and Disease Control, College of Animal Science and Technology, Anhui Agricultural University, Hefei 230036, PR China. Electronic address: qkz@ahau.edu.cn." } }, { "@type": "Person", "name": "Eduardo A Ceccarelli", "url": "https://questionsmedicales.fr/author/Eduardo%20A%20Ceccarelli", "affiliation": { "@type": "Organization", "name": "Instituto de Biología Molecular y Celular de Rosario (IBR), CONICET, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Rosario, Argentina." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Antineutrophil Cytoplasm Antibody-Associated Vasculitides Valvular Impairment: Multicenter Retrospective Study and Systematic Review of the Literature.", "datePublished": "2022-07-15", "url": "https://questionsmedicales.fr/article/35840158", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3899/jrheum.211379" } }, { "@type": "ScholarlyArticle", "name": "Ophthalmic histiocytic lesions (diseases of the L group): A multicenter clinicopathological study of 18 cases and review of literature.", "datePublished": "2022-07-11", "url": "https://questionsmedicales.fr/article/35816372", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/11206721221113431" } }, { "@type": "ScholarlyArticle", "name": "Modified prolonged exposure therapy as Early Intervention after Rape (The EIR-study): study protocol for a multicenter randomized add-on superiority trial.", "datePublished": "2023-02-21", "url": "https://questionsmedicales.fr/article/36810120", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13063-023-07147-w" } }, { "@type": "ScholarlyArticle", "name": "Pathogen spectrum and immunotherapy in patients with anti-IFN-γ autoantibodies: A multicenter retrospective study and systematic review.", "datePublished": "2022-12-08", "url": "https://questionsmedicales.fr/article/36569827", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2022.1051673" } }, { "@type": "ScholarlyArticle", "name": "Clinical efficacy of mandibular complete dentures with a resilient liner: study protocol for a multicenter randomized controlled trial.", "datePublished": "2022-09-02", "url": "https://questionsmedicales.fr/article/36056410", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13063-022-06657-3" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines bactériennes", "item": "https://questionsmedicales.fr/mesh/D001426" }, { "@type": "ListItem", "position": 5, "name": "Protéines Escherichia coli", "item": "https://questionsmedicales.fr/mesh/D029968" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Protéines Escherichia coli - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Protéines Escherichia coli", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Protéines Escherichia coli", "description": "Comment diagnostiquer une infection par E. coli ?\nQuels tests sont utilisés pour détecter les protéines E. coli ?\nQuels symptômes indiquent une infection par E. coli ?\nLes tests sanguins sont-ils utiles pour E. coli ?\nComment différencier E. coli des autres bactéries ?", "url": "https://questionsmedicales.fr/mesh/D029968?mesh_terms=Multicenter+Studies+as+Topic&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Protéines Escherichia coli", "description": "Quels sont les symptômes d'une intoxication alimentaire par E. coli ?\nE. coli peut-elle causer des infections urinaires ?\nQuels signes indiquent une infection grave par E. coli ?\nLes symptômes d'E. coli varient selon le type ?\nComment les symptômes d'E. coli se manifestent-ils chez les enfants ?", "url": "https://questionsmedicales.fr/mesh/D029968?mesh_terms=Multicenter+Studies+as+Topic&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Protéines Escherichia coli", "description": "Comment prévenir les infections à E. coli ?\nLes aliments crus sont-ils un risque pour E. coli ?\nLe lavage des mains réduit-il le risque d'E. coli ?\nFaut-il cuire la viande pour éviter E. coli ?\nLes voyages augmentent-ils le risque d'infection par E. coli ?", "url": "https://questionsmedicales.fr/mesh/D029968?mesh_terms=Multicenter+Studies+as+Topic&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Protéines Escherichia coli", "description": "Quel est le traitement standard pour une infection par E. coli ?\nLes antibiotiques sont-ils toujours nécessaires pour E. coli ?\nComment traiter la déshydratation due à E. coli ?\nY a-t-il des traitements spécifiques pour les souches E. coli pathogènes ?\nLes probiotiques aident-ils après une infection par E. coli ?", "url": "https://questionsmedicales.fr/mesh/D029968?mesh_terms=Multicenter+Studies+as+Topic&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Protéines Escherichia coli", "description": "Quelles sont les complications possibles d'une infection par E. coli ?\nE. coli peut-elle causer des complications rénales ?\nComment les complications d'E. coli sont-elles traitées ?\nLes complications d'E. coli sont-elles fréquentes ?\nQuels facteurs augmentent le risque de complications par E. coli ?", "url": "https://questionsmedicales.fr/mesh/D029968?mesh_terms=Multicenter+Studies+as+Topic&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Protéines Escherichia coli", "description": "Quels sont les principaux facteurs de risque d'infection par E. coli ?\nLes personnes âgées sont-elles plus à risque d'E. coli ?\nLes enfants sont-ils plus vulnérables aux infections à E. coli ?\nLe système immunitaire affaibli augmente-t-il le risque d'E. coli ?\nLes voyages à l'étranger augmentent-ils le risque d'E. coli ?", "url": "https://questionsmedicales.fr/mesh/D029968?mesh_terms=Multicenter+Studies+as+Topic&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection par E. coli ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic se fait par culture bactérienne et tests de sensibilité aux antibiotiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les protéines E. coli ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests immunologiques et des techniques de biologie moléculaire sont utilisés." } }, { "@type": "Question", "name": "Quels symptômes indiquent une infection par E. coli ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent diarrhée, douleurs abdominales et parfois fièvre." } }, { "@type": "Question", "name": "Les tests sanguins sont-ils utiles pour E. coli ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests sanguins peuvent détecter des signes d'infection systémique." } }, { "@type": "Question", "name": "Comment différencier E. coli des autres bactéries ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des tests biochimiques spécifiques et des méthodes moléculaires permettent cette différenciation." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une intoxication alimentaire par E. coli ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des crampes abdominales, diarrhée sanglante et vomissements." } }, { "@type": "Question", "name": "E. coli peut-elle causer des infections urinaires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, E. coli est une cause fréquente d'infections urinaires, provoquant douleur et brûlures." } }, { "@type": "Question", "name": "Quels signes indiquent une infection grave par E. coli ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme la déshydratation sévère, la confusion ou la fièvre élevée sont préoccupants." } }, { "@type": "Question", "name": "Les symptômes d'E. coli varient selon le type ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, différents types d'E. coli peuvent provoquer des symptômes variés, allant de légers à graves." } }, { "@type": "Question", "name": "Comment les symptômes d'E. coli se manifestent-ils chez les enfants ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Chez les enfants, les symptômes peuvent inclure diarrhée, vomissements et irritabilité." } }, { "@type": "Question", "name": "Comment prévenir les infections à E. coli ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par une bonne hygiène alimentaire et le lavage des mains." } }, { "@type": "Question", "name": "Les aliments crus sont-ils un risque pour E. coli ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les aliments crus, notamment la viande et les légumes, peuvent être contaminés par E. coli." } }, { "@type": "Question", "name": "Le lavage des mains réduit-il le risque d'E. coli ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un lavage des mains régulier réduit significativement le risque d'infection." } }, { "@type": "Question", "name": "Faut-il cuire la viande pour éviter E. coli ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, cuire la viande à la bonne température élimine le risque d'infection par E. coli." } }, { "@type": "Question", "name": "Les voyages augmentent-ils le risque d'infection par E. coli ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les voyages dans des régions à risque peuvent augmenter l'exposition à E. coli." } }, { "@type": "Question", "name": "Quel est le traitement standard pour une infection par E. coli ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement standard inclut l'hydratation et, dans certains cas, des antibiotiques." } }, { "@type": "Question", "name": "Les antibiotiques sont-ils toujours nécessaires pour E. coli ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Non, les antibiotiques ne sont pas toujours recommandés, surtout pour les souches productrices de toxines." } }, { "@type": "Question", "name": "Comment traiter la déshydratation due à E. coli ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La déshydratation est traitée par des solutions de réhydratation orale ou intraveineuse." } }, { "@type": "Question", "name": "Y a-t-il des traitements spécifiques pour les souches E. coli pathogènes ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines souches nécessitent des traitements spécifiques basés sur leur résistance aux antibiotiques." } }, { "@type": "Question", "name": "Les probiotiques aident-ils après une infection par E. coli ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les probiotiques peuvent aider à restaurer la flore intestinale après une infection." } }, { "@type": "Question", "name": "Quelles sont les complications possibles d'une infection par E. coli ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent le syndrome hémolytique et urémique, et des infections systémiques." } }, { "@type": "Question", "name": "E. coli peut-elle causer des complications rénales ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines souches d'E. coli peuvent entraîner des complications rénales graves." } }, { "@type": "Question", "name": "Comment les complications d'E. coli sont-elles traitées ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement des complications peut nécessiter des soins intensifs et des interventions médicales." } }, { "@type": "Question", "name": "Les complications d'E. coli sont-elles fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont rares mais peuvent survenir, surtout chez les personnes vulnérables." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de complications par E. coli ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les jeunes enfants, les personnes âgées et celles avec un système immunitaire affaibli sont à risque." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque d'infection par E. coli ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux facteurs incluent la consommation d'aliments contaminés et le contact avec des animaux." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque d'E. coli ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées ont un risque accru d'infections graves par E. coli." } }, { "@type": "Question", "name": "Les enfants sont-ils plus vulnérables aux infections à E. coli ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes enfants sont plus susceptibles de développer des infections graves." } }, { "@type": "Question", "name": "Le système immunitaire affaibli augmente-t-il le risque d'E. coli ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un système immunitaire affaibli augmente le risque d'infections et de complications." } }, { "@type": "Question", "name": "Les voyages à l'étranger augmentent-ils le risque d'E. coli ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des pays avec des normes sanitaires faibles augmente le risque d'infection." } } ] } ] }

Sources (10000 au total)

Antineutrophil Cytoplasm Antibody-Associated Vasculitides Valvular Impairment: Multicenter Retrospective Study and Systematic Review of the Literature.

While myocardial impairment is a predictor of poor prognosis in antineutrophil cytoplasm antibody (ANCA)-associated vasculitides (AAV), little is known about valvular involvement. This study aims at d... We conducted a multicenter retrospective study in centers affiliated with the French Vasculitis Study Group. We included patients with granulomatosis with polyangiitis (GPA), microscopic polyangiitis ... The retrospective cohort included 9 patients (82%) with GPA, 1 (9%) with MPA, and 1 (9%) with unclassified AAV. Clinical presentation included acute valvular insufficiency (n = 7, 64%), cardiac failur... Endocarditis is a rare and potentially life-threatening manifestation of AAV. Acute valvular insufficiency may lead to urgent surgery. Implementing transthoracic echocardiography in standard assessmen...

Ophthalmic histiocytic lesions (diseases of the L group): A multicenter clinicopathological study of 18 cases and review of literature.

Langerhans cell histiocytosis (LCH) and Erdheim-Chester disease (ECD) are rare histiocytic disorders in the L (Langerhans) group diseases. They range from self-limited benign diseases to lethal dissem... This retrospective study was conducted in 3 tertiary hospitals in Saudi Arabia and Brazil. Histopathological records were searched for all patients diagnosed with ocular and periocular histiocytic dis... Twenty-two eyes of 18 patients with biopsy-proven histiocytic disorders in the L group were included. Female-to-male ratio was 1.25:1. Average age at presentation was 14 years (range, 1-54). LCH was d... Histiocytic disorders are a rare group of diseases, including the L group. Relevant systemic associations require specific and selective therapy. A high clinical index and multidisciplinary collaborat...

Modified prolonged exposure therapy as Early Intervention after Rape (The EIR-study): study protocol for a multicenter randomized add-on superiority trial.

Sexual assault and rape are the traumatic life events with the highest probability for posttraumatic stress disorder (PTSD), which can have devastating consequences for those afflicted by the conditio... This is a multicenter randomized controlled add-on superiority trial that enrolls patients attending sexual assault centers within 72 h after rape or attempted rape. The objective is to assess whether... This study will guide further research and clinical initiatives for implementing strategies for preventing post-traumatic stress symptoms after rape and provide new knowledge about which women may ben... ClinicalTrials.gov NCT05489133. Registered on 3 August 2022....

Pathogen spectrum and immunotherapy in patients with anti-IFN-γ autoantibodies: A multicenter retrospective study and systematic review.

Anti-interferon-γ autoantibody (AIGA) positivity is an emerging immunodeficiency syndrome closely associated with intracellular infection in individuals without human immunodeficiency virus (HIV). How... This systematic literature review and multicenter retrospective study aimed to describe the pathogen spectrum and review treatment strategies among patients with AIGA positivity.... We included 810 HIV-negative patients with AIGA positivity infected with one or more intracellular pathogens. Excluding four teenagers, all the patients were adults. The most common pathogen was nontu... Intracellular pathogen was the most common infection in patients with AIGA positivity. The predominant infection phenotypes were NTM, varicella-zoster virus,...

Clinical efficacy of mandibular complete dentures with a resilient liner: study protocol for a multicenter randomized controlled trial.

During restoration of poorly fitting complete dentures (CDs) in edentulous patients, liners are used to reconstruct the concave surfaces of CDs with a new base material. These relining materials are c... The study is currently being conducted at eight centers, and a parallel-group randomized controlled trial (RCT) is underway. One hundred thirty-two edentulous patients with poorly fitting mandibular C... For dentists and prosthetic researchers in Japan, this RCT will provide information on the clinical efficacy of RL materials in comparison to RNL in CD wearers. The new evidence regarding the use of R... This clinical trial has been registered at the University Hospital Medical Information Network (UMIN) Center (UMIN000041950)....

Lifestyles, arterial aging, and its relationship with the intestinal and oral microbiota (MIVAS III study): a research protocol for a cross-sectional multicenter study.

The microbiota is increasingly recognized as a significant factor in the pathophysiology of many diseases, including cardiometabolic diseases, with lifestyles probably exerting the greatest influence ... MIVAS III is a multicenter cross-sectional study that will take place in the Iberian Peninsula. One thousand subjects aged between 45 and 74 years without cardiovascular disease will be selected. The ... Lifestyle acts as a modifier of microbiota composition. However, there are no conclusive results demonstrating the mediating effect of the microbiota in the relationship between lifestyles and cardiov... clinicaltrials.gov/ct2/show/NCT04924907, ClinicalTrials.gov, identifier: NCT04924907. Registered on 21 April 2021....

Cepharanthine and Oral Lichen Planus Efficacy (COLE) study: protocol for a multicentre randomised controlled study assessing the efficacy and safety of cepharanthine with topical corticosteroids in oral lichen planus.

Oral lichen planus (OLP) is a chronic, inflammatory oral condition leading to a range of symptoms from mild discomfort to severe pain, affecting patients' quality of life. Standard therapy involves th... This open-label, parallel-group, multi-centre, randomised controlled study will be conducted at three Japanese hospitals. It will compare safety and efficacy of integrated oral cepharanthine and corti... This protocol was approved by the Certified Review Board of Nara Medical University (CRB5200002). Participants will provide informed consent. Results will be disseminated in peer-reviewed journals and... Japan Registry of Clinical Trials (jRCTs051220130)....

Efficacy of methylene blue in refractory septic shock: study protocol for a multicenter, randomized, placebo-controlled trial.

Septic shock is now the leading cause of mortality in intensive care units (ICUs). Refractory septic shock requires high doses of vasopressors. Some previous studies have revealed that methylene blue ... This study is a multicenter, randomized, placebo-controlled trial planning to include 100 refractory septic shock patients. The protocol is to administer a bolus of 2 mg/kg methylene blue intravenousl... This protocol aims to evaluate the safety and efficacy of methylene blue as adjuvant therapy for refractory septic shock. The main outcome measure will be vasopressor requirements and hemodynamic para... This clinical trial has been registered at ChiCTR ( https://www.chictr.org.cn/ ) on March 16, 2023. ChiCTR registration number: ChiCTR2300069430....

Mainstream germline genetic testing in men with metastatic prostate cancer: design and protocol for a multicenter observational study.

In international guidelines, germline genetic testing is recommended for patients with metastatic prostate cancer. Before undergoing germline genetic testing, these patients should receive pre-test co... A multicenter prospective observational cohort study will be conducted in 15 hospitals, in different regions of the Netherlands. We developed an online training module on genetics in prostate cancer a... This study is intended to be one of the largest studies on mainstream genetic testing in prostate cancer. The results of this study can improve the mainstream genetic testing pathway in patients with ... The study is registered in the WHO's International Clinical Trials Registry Platform (ICTRP) under number NL9617....

Staging LaParoscopy to Assess Lymph NOde InvoLvement in Advanced GAstric Cancer (POLA)-Study protocol for a single-arm prospective observational multicenter study.

In the era of neoadjuvant chemotherapy in advanced gastric cancer (GC), the role of staging laparoscopy (SL) will become more established. However, despite guidelines recommendations, SL for optimal p... This single-arm prospective observational multicenter study was approved by the Bioethical Committee of Medical University of Lublin (Ethic Code: KE-0254/331/2018). The protocol is registered at clini... POLA study is the first to investigate the clinical value of ICG-enhanced sentinel node biopsy during staging laparoscopy in advanced GC patients in a Western cohort. Identifying pN status before mult...